Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Biomedicines|May 25, 2024
Therapy-Related Myeloid Neoplasm: Biology and Mechanistic Aspects of Malignant ProgressionSerena Travaglini, Massimiliano Marinoni, Valeria Visconte, et al.Current Opinion in Oncology|September 9, 2024
Advances in the pathogenesis of FLT3 -mutated acute myeloid leukemia and targeted treatmentsSerena Travaglini, Carmelo Gurnari, Tiziana Ottone, et al.Journal of Personalized Medicine|September 26, 2025
Metabolic Signature of FLT3-Mutated AML: Clinical and Therapeutic ImplicationsCristina Banella, Gianfranco Catalano, Maura Calvani, et al.Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Combination Treatment of Resistant Acute Promyelocytic Leukemia Cells with Arsenic Trioxide and Anti-Apoptotic Gene InhibitorsManuela Giansanti, Tiziana Ottone, Serena Travaglini, et al.Biology|February 10, 2021
From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer ProgressionCarmelo Gurnari, Emiliano Fabiani, Giulia Falconi, et al.Mechanisms of Ageing and Development|May 13, 2023
A minimal promoter region of Kit gene recapitulates mast cell differentiation in development, aging and inflammationSerena Fuda, Daniela F Angelini, Ambra Colopi, et al.Cancers|January 8, 2020
PML/RARa Interferes with NRF2 Transcriptional Activity Increasing the Sensitivity to Ascorbate of Acute Promyelocytic Leukemia CellsCristina Banella, Gianfranco Catalano, Serena Travaglini, et al.Frontiers in Oncology|May 2, 2022
Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and PrognosisLuca Guarnera, Tiziana Ottone, Emiliano Fabiani, et al.Scientific Reports|December 9, 2022
Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesisGiulia Falconi, Elisa Galossi, Emiliano Fabiani, et al.British Journal of Haematology|December 12, 2018
PML/RARA inhibits expression of HSP90 and its target AKTMaria Liliana Piredda, Girish Gaur, Gianfranco Catalano, et al.Pageof 3